Cigna Investments’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.02M | Sell |
23,473
-203
| -0.9% | -$23.8K | 0.39% | 39 |
|
|
2026
Q1 | $2.85M | Sell |
23,676
-648
| -3% | -$74.8K | 0.44% | 35 |
|
|
2025
Q4 | $2.56M | Sell |
24,324
-331
| -1% | -$31.1K | 0.37% | 42 |
|
|
2025
Q3 | $2.07M | Sell |
24,655
-83
| -0.3% | -$6.84K | 0.29% | 49 |
|
|
2025
Q2 | $1.96M | Sell |
24,738
-772
| -3% | -$61.4K | 0.33% | 50 |
|
|
2025
Q1 | $2.29M | Sell |
25,510
-462
| -2% | -$43.1K | 0.43% | 36 |
|
|
2024
Q4 | $2.58M | Sell |
25,972
-158
| -0.6% | -$16.3K | 0.45% | 30 |
|
|
2024
Q3 | $2.97M | Sell |
26,130
-351
| -1% | -$41.7K | 0.52% | 27 |
|
|
2024
Q2 | $3.28M | Sell |
26,481
-425
| -2% | -$54.7K | 0.61% | 23 |
|
|
2024
Q1 | $3.55M | Sell |
26,906
-183
| -0.7% | -$22.6K | 0.67% | 22 |
|
|
2023
Q4 | $2.95M | Sell |
27,089
-200
| -0.7% | -$20.8K | 0.61% | 23 |
|
|
2023
Q3 | $2.81M | Sell |
27,289
-3,460
| -11% | -$373K | 0.64% | 24 |
|
|
2023
Q2 | $3.55M | Buy |
30,749
+6
| +0% | +$681 | 0.66% | 24 |
|
|
2023
Q1 | $3.27M | Sell |
30,743
-522
| -2% | -$56.4K | 0.65% | 25 |
|
|
2022
Q4 | $3.47M | Buy |
31,265
+114
| +0.4% | +$11.7K | 0.72% | 25 |
|
|
2022
Q3 | $2.68M | Sell |
31,151
-1,474
| -5% | -$132K | 0.59% | 29 |
|
|
2022
Q2 | $2.98M | Sell |
32,625
-13,860
| -30% | -$1.23M | 0.59% | 29 |
|
|
2022
Q1 | $3.81M | Sell |
46,485
-10,902
| -19% | -$860K | 0.47% | 37 |
|
|
2021
Q4 | $4.4M | Sell |
57,387
-20,193
| -26% | -$1.61M | 0.34% | 53 |
|
|
2021
Q3 | $5.83M | Sell |
77,580
-1,444
| -2% | -$110K | 0.43% | 46 |
|
|
2021
Q2 | $6.14M | Sell |
79,024
-16,443
| -17% | -$1.22M | 0.44% | 43 |
|
|
2021
Q1 | $7.02M | Buy |
95,467
+2,707
| +3% | +$200K | 0.48% | 38 |
|
|
2020
Q4 | $7.24M | Buy |
92,760
+7,193
| +8% | +$550K | 0.56% | 29 |
|
|
2020
Q3 | $6.77M | Sell |
85,567
-15,009
| -15% | -$1.18M | 0.65% | 27 |
|
|
2020
Q2 | $7.42M | Buy |
100,576
+10,763
| +12% | +$810K | 0.7% | 25 |
|
|
2020
Q1 | $6.59M | Buy |
89,813
+16,827
| +23% | +$1.32M | 0.85% | 17 |
|
|
2019
Q4 | $5.95M | Sell |
72,986
-8,206
| -10% | -$674K | 0.63% | 26 |
|
|
2019
Q3 | $6.71M | Sell |
81,192
-1,019
| -1% | -$81.7K | 0.69% | 25 |
|
|
2019
Q2 | $6.51M | Buy |
82,211
+930
| +1% | +$71.2K | 0.71% | 25 |
|
|
2019
Q1 | $6.45M | Sell |
81,281
-10,342
| -11% | -$774K | 0.71% | 26 |
|
|
2018
Q4 | $6.68M | Buy |
91,623
+10,168
| +12% | +$718K | 0.57% | 22 |
|
|
2018
Q3 | $5.72M | Sell |
81,455
-8,395
| -9% | -$535K | 0.46% | 30 |
|
|
2018
Q2 | $5.2M | Sell |
89,850
-14,993
| -14% | -$846K | 0.38% | 35 |
|
|
2018
Q1 | $5.45M | Sell |
104,843
-911
| -0.9% | -$49.2K | 0.37% | 37 |
|
|
2017
Q4 | $5.68M | Sell |
105,754
-25,456
| -19% | -$1.41M | 0.37% | 38 |
|
|
2017
Q3 | $8.02M | Sell |
131,210
-1,394
| -1% | -$84.5K | 0.53% | 24 |
|
|
2017
Q2 | $8.17M | Sell |
132,604
-27,897
| -17% | -$1.7M | 0.56% | 20 |
|
|
2017
Q1 | $9.8M | Buy |
160,501
+12,316
| +8% | +$747K | 0.67% | 18 |
|
|
2016
Q4 | $8.32M | Buy |
+148,185
| New | +$8.67M | 0.91% | 19 |
|
Other funds holding MRK
ECSS
Cigna Investments's MRK Position: Q2 2026 in Review
Cigna Investments reduced its Merck (MRK) stake by 0.86% in Q2 2026, selling an estimated $23.8K and leaving 23,473 shares worth $3.02M. The position accounts for 0.39% of the portfolio, ranked #39.
Cigna Investments first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $9.8M in Q1 2017. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Cigna Investments held 23,473 shares of Merck worth $3.02M as of Q2 2026.
- Cigna Investments sold 203 Merck shares in Q2 2026, an estimated $23.8K.
- Merck made up 0.39% of Cigna Investments's portfolio in Q2 2026, its #39 holding.
- Cigna Investments first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Merck position peaked at $9.8M in Q1 2017.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.